Camille L. Bedrosian, Chief Medical Officer: Amylyx Pharmaceuticals AMLX Sell · Filed 25/10/02

Trade details

Type: Insider sale
Amount: $175,528.62
Shares · price: 12,039 sh · $14.58 a share
Held after: 182,336 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: Camille L. BedrosianChief Medical Officer
Trade date: 25/09/30
Filed: 25/10/02
Days to filing: 2 days

Sold 6.2% of holdings

Share of holding sold: 6.2%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Camille L. Bedrosian's recent trades

Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$324.9K
10,028 sh
$324.9K
Filed 09/11
Traded 09/10
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$5.8M
64,540 sh
$5.8M
Filed 03/04
Traded 03/04
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/04
Traded 03/02
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$3.2M
35,460 sh
$3.2M
Filed 03/03
Traded 03/03
Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/02
Traded 03/02